Synthesis of some coumarinyl chalcones and their antiproliferative activity against breast cancer cell lines

Letters in Drug Design and Discovery

Volumn 8, Issue 4, 2011, Pages 308-311

  Patel, Kuldeep ^a   Karthikeyan, Chandrabose ^a   Solomon, Viswas Raja ^b,c   Moorthy, N S Hari Narayana ^a,d   Lee, Hoyun ^b,c   Sahu, Kapendra ^a   Deora, Girdhar Singh ^a   Trivedi, Piyush ^a  

^a UNIVERSITY INSTITUTE OF TECHNOLOGY   (India)

^b Regional Hospital   (Canada)

^c LAURENTIAN UNIVERSITY   (Canada)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

184B5; Antiproliferative activity; Breast cancer cell lines; Coumarinyl chalcones

Indexed keywords

CISPLATIN; COUMARIN DERIVATIVE; COUMARINYL CHALCONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 79955943918     PISSN: 15701808     EISSN: 1875628X     Source Type: Journal    
DOI: 10.2174/157018011794839475     Document Type: Article

References (36)

1. Fadeyi, O.O.; Adamson, S.T.; Myles, E.L.; Okoro, CO. Novel fluorinated acridone derivatives. Part 1: Synthesis and evaluation as potential anticancer agents. Bioorg. Med. Chem. Lett., 2008, 18, 4172-4176.
2. Sherif, A.; Rostom, F. Synthesis and in vitro antitumor evaluation of some indeno[1,2-c]pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores, and some derived thiazole ring systems. Bioorg. Med. Chem., 2006, 14, 6475-6485.
3. http://www.who.int/mediacentre/factsheets/fs297/en/index.html
4. Hsu, Y.L.; Kuo, P.L.; Tzeng, W.S.; Lin, C.C. Chalcone inhibits the proliferation of human breast cancer cell by blocking cell cycle progression and inducing apoptosis. Food Chem. Toxicol., 2006, 44, 704-713.
5. Baselga, J.; Mendelsohn, J. The epidermal growth factor receptor as a target for therapy in breast carcinoma. Breast Cancer Res. Treat., 1994, 29, 127-138. (Pubitemid 24104844)
6. Bandgar, B.P.; Gawande, S.S.; Bodade, R.G.; Totre, J.V.; Khobragade, C.N. Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents. Bioorg. Med. Chem., 2010, 18, 1364-1370.
7. Martirosyan, A.; Rahim-Bata, R.; Freeman, A.; Clarke, C.; Howard, R.; Strobl, J. Differentiation-inducing quinolines as experimental breast cancer agents in the MCF-7 human cancer cell model. Biochem. Pharmacol., 2004, 68, 1729-1738. (Pubitemid 39278495)
8. Mól, W.; Matyja, M.; Filip, B.; Wietrzyk, S. Synthesis and antiproliferative activity in vitro of novel (2-buthynyl)thioquinolines. Bioorg. Med. Chem., 2008, 16, 8136-8141.
9. Hu, L.; Jiang, J-D.; Qu, J.; Li, Y.; Jin, J.; Li, Z-R.; Boykin, D.W. Novel potent antimitotic heterocyclic ketones: Synthesis, antiproliferative activity, and structure-activity relationships. Bioorg. Med. Chem. Lett., 2007, 17, 3613-3617. (Pubitemid 46898827)
10. Issa, S.; Walchshofer, N.; Kassab, I.; Termoss, H.; Chamat, S.; Geahchan, A.; Bouaziz, Z. Synthesis and antiproliferative activity of oxazinocarbazole and NN-bis(carbazolylmethyl)amine derivatives. Eur. J. Med. Chem., 2010, 45, 2567-2577.
11. Hadjikakou, S.K.; Hadjiliadis, N. Antiproliferative and anti-tumor activity of organotin compounds. Coord. Chem. Rev., 2009, 253, 235-249.
12. Solomon, V.R.; Hu, C.; Lee, H. Design and synthesis of chloroquine analogs with anti-breast cancer property. Eur. J. Med. Chem., 2010, 45, 3916-3923.
13. Solomon, V.R.; Hu, C.; Lee, H. Hybrid pharmacophore design and synthesis of isatin-benzothiazole analogs for their anti-breast cancer activity. Bioorg. Med. Chem., 2009, 17, 7585-7592.
14. Solomon, V.R.; Hu, C.; Lee, H. Design and synthesis of anti-breast cancer agents from 4-piperazinylquinoline: a hybrid pharmacophore approach. Bioorg. Med. Chem., 2010, 18, 1563-1572.
15. Agarwala, P.K. Carbon-13 NMR of flavonoids. Elsevier Science Publishers B. V: The Netherlands, 1989.
16. Begum, N.A.; Roy, N.; Laskar, R.A.; Roy, K. Mosquito larvicidal studies of some chalcone analogues and their derived products: structure-activity relationship analysis. Med. Chem. Res., 2010, doi10.1007/s00044-010-9305-6.
17. Go, M.L.; Wu, X.; Liu, X.L. Chalcones: an update on cytotoxic and hemoprotective properties. Curr. Med. Chem., 2005, 12, 481-499.
18. Chimenti, F.; Fioravanti, R.; Bolasco, A.; Chimenti, P.; Secci, D.; Rossi, R.; Ya'ñez, M.; Orallo, F.; Ortuso, F.; Alcaro, S. Chalcones: A valid scaffold for monoamine oxidases inhibitors. J. Med. Chem., 2009, 52, 2818-2824.
19. Liu, M.; Wilairat, P.; Go, M-L. Antimalarial alkoxylated and hydroxylated chalones: Structure-activity relationship analysis. J. Med. Chem., 2001, 44, 4443-4452. (Pubitemid 33131668)
20. Ducki, S.; Forrest, R.; Hadfield, J.A.; Kendall, A.; Lawrence, N.J.; McGown, A.T.; Rennison, D. Potent antimitotic and cell growth inhibitory properties of substituted chalcones. Bioorg. Med. Chem. Lett., 1998, 8, 1051-1056. (Pubitemid 28216282)
21. Bois, F.; Boumendjel, A.; Mariotte, A.; Conseil, G.; Di Petro, A. Synthesis and biological activity of 4-alkoxychalcones: potential hydrophobic modulators of P-glycoprotein-mediated multidrug resistance. Bioorg. Med. Chem., 1999, 7, 2691-2695. (Pubitemid 30105841)
22. Dimmock, J.R.; Elias, D.W.; Beazely, M.A.; Kandepu, N.M. Bioactivities of chalcones. Curr. Med. Chem., 1999, 6, 1125-1149.
23. Hsu, Y.L.; Kuo, P.L.; Chiang, L.C.; Lin, C.C. Isoliquiritigenin inhibits the proliferation and induces the apoptosis of human non- small cell lung cancer a549 cells. Clin. Exp. Pharmacol. Physiol., 2004, 31, 414-418.
24. Fu, Y.; Hsieh, T.C.; Guo, J.; Kunicki, J.; Lee, M.Y.; Darzynkiewicz, Z.; Wu, J.M. Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells. Biochem. Biophys. Res. Commun., 2004, 322, 263-270. (Pubitemid 39093864)
25. Zi, X.; Simoneau, A.R. Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice. Cancer Res., 2005, 65, 3479-3486. (Pubitemid 40524635)
26. Tabata, K.; Motani, K.; Takayanagi, N.; Nishimura, R.; Asami, S.; Kimura, Y.; Ukiya, M.; Hasegawa, D.; Akihisa, T.; Suzuki, T. Xanthoangelol, a major chalcone constituent of Angelica keiskei, induces apoptosis in neuroblastoma and leukemia cells. Biol. Pharm. Bull., 2005, 28, 1404-1407. (Pubitemid 41379689)
27. Takahashi, T.T.; Takasuka, N.; Ligo, M.; Baba, M.; Nishino, H.; Tsuda, H.; Okuyama, T. Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. Cancer Sci., 2004, 95, 448-453. (Pubitemid 38832690)
28. Samoszuk, M.; Tan, J.; Chorn, G. The chalcone butein from Rhus verniciflua Stokes inhibits clonogenic growth of human breast cancer cells co-cultured with fibroblasts. BMC Complement. Altern. Med., 2005, 5, 5. doi:10.1186/1472-6882-5-5 (Pubitemid 41364089)
29. Sharma, A.; Chakravarti, B.; Gupt, M.P.; Siddiqui, J.A.; Konwar, R.; Tripathi, R.P. Synthesis and anti breast cancer activity of biphenyl based chalcones. Bioorg. Med. Chem., 2010, 18, 4711-4720.
30. Liu, X-L.; Tee, H.W.; Go, M-L. Functionalized chalcones as selective inhibitors of P-glycoprotein and breast cancer resistance protein. Bioorg. Med. Chem., 2008, 16, 171-180.
31. Moorthy, N.S.H.N.; Karthikeyan, C.; Trivedi, P. Synthesis, cytotoxic evaluation and in silico pharmacokinetic prediction of some benzo[a]phenazine-5- sulfonic acid derivatives. Med. Chem., 2009, 5, 549-557.
32. Moorthy, N.S.H.N.; Karthikeyan, C.; Trivedi, P. Design, synthesis, cytotoxic evaluation and QSAR study of some 6H-indolo[2,3- b]quinoxaline derivatives. J. Enz. Inhibit. Med. Chem., 2010, 25, 394-405.
33. Trivedi, J.C.; Bariwal, J.B.; Upadhyay, K.D.; Naliapara, Y.T.; Joshi, S.K.; Pannecouque, C.C.; De Clercq, E.; Shah, A.K. Improved and rapid synthesis of new coumarinyl chalcone derivatives and their antiviral activity. Tetrahedron Lett., 2007, 48, 8472-8474. (Pubitemid 350016206)
34. See supplementary information
35. Hu, C.; Solomon, V.R.; Ulibarri, G.; Lee, H. The efficacy and selectivity of tumor cell killing by Akt inhibitors are substantially increased by chloroquine. Bioorg. Med. Chem., 2008, 16, 7888-7893.
36. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 1990, 82, 1107-1112. (Pubitemid 20213250)